Cytotoxic gold compounds: synthesis, biological characterization and investigation of their inhibition properties of the zinc finger protein PARP-1
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cytotoxic gold compounds: synthesis, biological characterization and investigation of their inhibition properties of the zinc finger protein PARP-1
Authors
Keywords
-
Journal
DALTON TRANSACTIONS
Volume 41, Issue 11, Pages 3287
Publisher
Royal Society of Chemistry (RSC)
Online
2012-01-31
DOI
10.1039/c2dt11913g
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular Mechanisms and Proposed Targets for Selected Anticancer Gold Compounds
- (2011) Angela Casini et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Bioinorganic and medicinal chemistry: aspects of gold(i)-protein complexes
- (2011) Krishna P. Bhabak et al. DALTON TRANSACTIONS
- Gold(i) complexes of water-soluble diphos-type ligands: Synthesis, anticancer activity, apoptosis and thioredoxin reductase inhibition
- (2011) Corinna Wetzel et al. DALTON TRANSACTIONS
- Multinuclear Cytotoxic Metallodrugs: Physicochemical Characterization and Biological Properties of Novel Heteronuclear Gold–Titanium Complexes
- (2011) Margot Wenzel et al. INORGANIC CHEMISTRY
- Metal-Based Inhibition of Poly(ADP-ribose) Polymerase − The Guardian Angel of DNA
- (2011) Filipa Mendes et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mechanistic studies on two dinuclear organogold(iii) compounds showing appreciable antiproliferative properties and a high redox stability
- (2011) Chiara Gabbiani et al. Metallomics
- Gold compounds as therapeutic agents for human diseases
- (2011) Susan J. Berners-Price et al. Metallomics
- Synthesis, characterisation and biological properties of gold(iii) compounds with modified bipyridine and bipyridylamine ligands
- (2010) Angela Casini et al. DALTON TRANSACTIONS
- Development of Bimetallic Titanocene−Ruthenium−Arene Complexes As Anticancer Agents: Relationships between Structural and Biological Properties
- (2010) Frédéric Pelletier et al. JOURNAL OF MEDICINAL CHEMISTRY
- Thioredoxin reductase, an emerging target for anticancer metallodrugs. Enzyme inhibition by cytotoxic gold(iii) compounds studied with combined mass spectrometry and biochemical assays
- (2010) Chiara Gabbiani et al. MedChemComm
- Structure validation in chemical crystallography
- (2009) Anthony L. Spek ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Anticancer Therapeutics That Target Selenoenzymes: Synthesis, Characterization, inâ vitro Cytotoxicity, and Thioredoxin Reductase Inhibition of a Series of Gold(I) Complexes Containing Hydrophilic Phosphine Ligands
- (2009) Elena Vergara et al. ChemMedChem
- On the medicinal chemistry of gold complexes as anticancer drugs
- (2009) Ingo Ott COORDINATION CHEMISTRY REVIEWS
- Thioredoxin reductase: A target for gold compounds acting as potential anticancer drugs
- (2009) Alberto Bindoli et al. COORDINATION CHEMISTRY REVIEWS
- The anti-cancer properties of gold(III) compounds with dianionic porphyrin and tetradentate ligands
- (2009) Raymond Wai-Yin Sun et al. COORDINATION CHEMISTRY REVIEWS
- The Midas touch in cancer chemotherapy: from platinum- to gold-dithiocarbamato complexes
- (2009) Luca Ronconi et al. DALTON TRANSACTIONS
- Groundbreaking gold(III) anticancer agents
- (2009) Donatella Aldinucci et al. DRUG DISCOVERY TODAY
- Towards Antitumor Activetrans-Platinum Compounds
- (2009) Sheena M. Aris et al. EUROPEAN JOURNAL OF INORGANIC CHEMISTRY
- Platinum Anticancer Coordination Compounds: Study of DNA Binding Inspires New Drug Design
- (2009) Jan Reedijk EUROPEAN JOURNAL OF INORGANIC CHEMISTRY
- Chemistry, antiproliferative properties, tumor selectivity, and molecular mechanisms of novel gold(III) compounds for cancer treatment: a systematic study
- (2009) Angela Casini et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- A unique chair-shaped hexanuclear Cu(I) metallamacrocyclic C2H4adduct encapsulating a BF4−anion
- (2008) Masahiko Maekawa et al. DALTON TRANSACTIONS
- Synthesis, Characterization, and in Vitro Cytotoxicity of Some Gold(I) and Trans Platinum(II) Thionate Complexes Containing Water-Soluble PTA and DAPTA Ligands. X-ray Crystal Structures of [Au(SC4H3N2)(PTA)],trans-[Pt(SC4H3N2)2(PTA)2],trans-[Pt(SC5H4N)2(PTA)2], andtrans-[Pt(SC5H4N)2(DAPTA)2]
- (2008) Susana Miranda et al. INORGANIC CHEMISTRY
- Structural Characterization, Solution Studies, and DFT Calculations on a Series of Binuclear Gold(III) Oxo Complexes: Relationships to Biological Properties
- (2008) Chiara Gabbiani et al. INORGANIC CHEMISTRY
- Mitochondria-Targeted Chemotherapeutics: The Rational Design of Gold(I)N-Heterocyclic Carbene Complexes That Are Selectively Toxic to Cancer Cells and Target Protein Selenols in Preference to Thiols
- (2008) James L. Hickey et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Anti-cancer potential of gold complexes
- (2008) E. R. T. Tiekink INFLAMMOPHARMACOLOGY
- Antitumour metal compounds: more than theme and variations
- (2007) Michael A. Jakupec et al. DALTON TRANSACTIONS
- Towards the rational design of platinum(ii) and gold(iii) complexes as antitumour agents
- (2007) Xiaoyong Wang et al. DALTON TRANSACTIONS
- In vitro antitumour and hepatotoxicity profiles of Au(I) and Ag(I) bidentate pyridyl phosphine complexes and relationships to cellular uptake
- (2007) Johnson J. Liu et al. JOURNAL OF INORGANIC BIOCHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started